The first academic research on Switzerland’s landmark adult-use pilot, has reported a decline in problematic consumption, particularly among those who...
France’s four-year campaign to launch a fully regulated generalised medical cannabis framework is finally being realised. Just weeks ago thousands...
Releaf examines what to consider when exploring this treatment option for yourself or a loved one.
The proposed changes are set to have a major impact on the country’s already booming market.
CBG, CBC, CBN, and CBDV have shown promise as anti-cancer agents in the treatment of blood cancer.
The UK’s Food Standards Agency (FSA) has issued its first positive safety assessment for a consortium application in its CBD Novel Foods approval process, seeing the...
Researchers have published findings from one of the first clinical trials on CBG in humans.
Cannabis and psychedelic medicine were firmly on the agenda at the major European health innovation conference.
The Czech government looks to be pursuing a full commercial adult-use cannabis market as part of its ‘Cannabis Management Act’, according to leaked documents seen by Business...
The team are now studying how CBD interacts in the mouse brain to better understand why the drug affects behaviour in this way.
The first data collected from the Grashaus Project in the canton of Basel-Landschaft has been published.
What does the new government mean for cannabis policy in the UK?
